CSIMarket
 


Biocorrx Inc   (BICX)
Other Ticker:  
 
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
 

BICX's EPS Net Growth by Quarter and Year

Biocorrx Inc 's EPS Net results by quarter and year




BICX EPS Net (in $) FY 2023 FY 2022 FY 2021 FY 2020
IV Quarter December - 0.46 -0.18 -0.17
III Quarter September -0.10 -0.13 -0.21 -0.14
II Quarter June -0.11 -0.19 -0.16 -0.14
I Quarter March -0.13 -0.14 -0.26 -0.20
FY   -0.34 0.00 -0.81 -0.65



BICX EPS Net third quarter 2023 Y/Y Growth Comment
Biocorrx Inc in the third quarter 2023 recorded EPS net loss of $ -0.10 .

According to the results reported in the third quarter 2023, Biocorrx Inc achieved the best EPS Net growth in Healthcare Facilities industry. While Biocorrx Inc ' s EPS Net no change of % ranks overall at the positon no. 27 in the third quarter 2023.




BICX EPS Net ( Y/Y Growth %) 2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Biocorrx Inc 's third quarter 2023 EPS Net $ -0.10 BICX's Income Statement
Biocorrx Inc 's third quarter 2022 EPS Net $ -0.13 Quarterly BICX's Income Statement
New: More BICX's historic EPS Net Growth >>


BICX EPS Net (Quarter on Quarter Growth %)

2023
2022 2021 2020
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #5
Overall #27

EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
EPS Net third quarter 2023 Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #1
Healthcare Sector #5
Overall #27
EPS Net Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

EPS Net by Quarter for the Fiscal Years 2020, 2021, 2022, 2023

Biocorrx Inc 's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BICX's III. Quarter Q/Q EPS Net Comment
Despite the fact, that Biocorrx Inc in the III. Quarter 2023 admitted EPS net loss of $ -0.10 , management mentioned, that this point to improvement compare to the -0.11 in the second quarter.

Within Healthcare Facilities industry Biocorrx Inc achieved highest sequential EPS Net growth. While Biocorrx Inc 's EPS Net growth quarter on quarter, overall rank is .


EPS Net Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #
EPS Net Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BICX's III. Quarter Q/Q EPS Net Comment
Although Biocorrx Inc in the III. Quarter 2023 revealed EPS net loss of $ -0.10 , management point out, that those numbers point to recovery in contrast to the -0.11 in the second quarter.

Within Healthcare Facilities industry Biocorrx Inc achieved highest sequential EPS Net growth. While Biocorrx Inc 's EPS Net growth quarter on quarter, overall rank is .


Biocorrx Inc 's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
12 Months Ending
(Sep 30 2022)
Cumulative EPS Net 12 Months Ending $ 0.12 $ 0.09 $ 0.01 $ 0.00 $ -0.64
Y / Y EPS Net Growth (TTM) - - - - -
Year on Year EPS Net Growth Overall Ranking # # # # #
Seqeuential EPS Net Change (TTM) 33.33 % 800 % - - -
Seq. EPS Net Growth (TTM) Overall Ranking # 34 # 27 # 0 # 0 # 0




Cumulative EPS Net growth Comment
In the Sep 30 2023 period, Biocorrx Inc had cumulative twelve months EPS Net of $ 0 compare to EPS net loss of $ -1 a year ago.
Besides Biocorrx Inc has restored the prosperity, it by this time is improving fast and recording above average EPS Net rise, from the twelve months ending in the quarter Jun 30 2023 of 33.33 % from $0.09 .

Biocorrx Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 5
S&P 500 # 34
Cumulative EPS Net growth Comment
In the Sep 30 2023 period, Biocorrx Inc had cumulative twelve months EPS Net of $ 0 compare to EPS net loss of $ -1 a year ago.
Even more so, not just that BICX has regained the prosperity, it is, as of now improving fast and recording better then normal EPS Net surge, from the period from Jun 30 2023 to Sep 30 2022 of 33.33 % from $0.09 .

Biocorrx Inc achieved highest trailing twelve month year on year EPS Net growth. While overall EPS Net growth ranking, remained unchanged compare to the previous quarter at no. .

EPS Net TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Healthcare Facilities Industry #
Healthcare Sector #
Overall #

EPS Net TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 5
S&P 500 # 34




Other EPS Net Growth
Healthcare Facilities Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
BICX's EPS Net Growth Ratio versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for BICX's Competitors
EPS Net Growth for Biocorrx Inc 's Suppliers
EPS Net Growth for BICX's Customers

You may also want to know
BICX's Annual Growth Rates BICX's Profitability Ratios BICX's Asset Turnover Ratio BICX's Dividend Growth
BICX's Roe BICX's Valuation Ratios BICX's Financial Strength Ratios BICX's Dividend Payout Ratio
BICX's Roa BICX's Inventory Turnover Ratio BICX's Growth Rates BICX's Dividend Comparisons



Companies with similar EPS Net no change for the quarter ending Sep 30 2023 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Sep 30 2023
National Research Corporation-3.03%$ -3.030 
Henry Schein Inc-3.67%$ -3.670 
Universal Health Services Inc -4.00%$ -4.000 
Mettler toledo International Inc -5.64%$ -5.635 
The Pennant Group Inc -6.25%$ -6.250 
Corcept Therapeutics Inc-6.67%$ -6.667 
Viatris Inc -6.90%$ -6.897 
Quest Diagnostics Inc-9.68%$ -9.677 
Charles River Laboratories International inc -10.11%$ -10.106 
Stryker Corp-15.89%$ -15.888 
Zimmer Biomet Holdings Inc -16.30%$ -16.304 
Tenet Healthcare Corp-18.97%$ -18.966 
Amgen Inc -19.10%$ -19.095 
Hologic Inc-22.69%$ -22.688 
Zynex inc -23.08%$ -23.077 
Dariohealth Corp -23.44%$ -23.438 
Regeneron Pharmaceuticals Inc -23.76%$ -23.756 
Entera Bio Ltd -27.27%$ -27.273 
U S Physical Therapy Inc-29.17%$ -29.167 
Pediatrix Medical Group Inc -29.73%$ -29.730 
Avantor Inc -36.00%$ -36.000 
Ufp Technologies Inc -40.63%$ -40.625 
Biomx Inc -43.48%$ -43.478 
Laboratory Corporation Of America Holdings-45.90%$ -45.897 
Royalty Pharma Plc-50.00%$ -50.000 
Staar Surgical Company-52.38%$ -52.381 
Abbvie inc -54.75%$ -54.751 
Repligen Corp-54.93%$ -54.930 
Envista Holdings Corporation-55.56%$ -55.556 
Oramed Pharmaceuticals Inc -55.56%$ -55.556 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com